CHAI Discovery offers De Novo Antibody Design
Product
AI platform for de novo antibody and protein design against challenging drug targets.
- Currently Offered
AI platform for de novo antibody and protein design against challenging drug targets.
Chai-2 enables commercial and academic teams to design antibodies and miniproteins with high success rates against membrane proteins and modified epitopes.
The platform supports format selection, epitope targeting, and faster characterization cycles without high-throughput screening.
Generate Platform is a generative biology platform that designs novel protein therapeutics.
Transformer-based AI platform from Atombio for aptamer discovery and optimization in days.
Absci's Integrated Drug Creation platform pairs generative-AI antibody design with its SoluPro microbial cell-line protein production system.
ProGen is Salesforce's open BSD-3 protein language-modeling suite for protein engineering and design.
AlphaFold is an AI system that predicts 3D protein structures from amino acid sequences, accelerating biological research and drug discovery.
HyperBind is an AI antibody design platform that learns from experimental feedback.
EvoGen is a generative AI platform that designs novel therapeutic proteins.
Generate Platform is a generative biology platform that designs novel protein therapeutics.
Transformer-based AI platform from Atombio for aptamer discovery and optimization in days.
Absci's Integrated Drug Creation platform pairs generative-AI antibody design with its SoluPro microbial cell-line protein production system.
ProGen is Salesforce's open BSD-3 protein language-modeling suite for protein engineering and design.
ESMFold is a protein structure prediction model developed by Meta AI that predicts 3D structures directly from protein sequences.
AlphaFold is an AI system that predicts 3D protein structures from amino acid sequences, accelerating biological research and drug discovery.